Research has demonstrated that both the mRNA and protein expression levels of INPP5J are markedly reduced in ovarian cancer (Zhu et al., 2015), breast cancer (Toker and Rameh, 2015), and pancreatic cancer (Zhou et al., 2024). The gene discussed is INPP5J; the disease is familial pancreatic carcinoma.